RecruitingNCT02806388
Individualized Molecular Profiling for Allocation to Clinical Trials (IMPACT) Project
Sponsor
National Cancer Centre, Singapore
Enrollment
5,500 participants
Start Date
Oct 1, 2011
Study Type
OBSERVATIONAL
Conditions
Summary
This study aims to screen tumor molecular profile for better selection of anticancer treatment, in particular, allocation to clinical trials if available.
Eligibility
Min Age: 12 Years
Inclusion Criteria5
- Confirmed histological diagnosis of solid tumor
- Suitable for systematic treatment and clinical trials
- ECOG (Eastern cooperative oncology group) performance status < 2
- Able to provide tumor tissue for molecular profiling
- Able to understand and sign the informed consent form
Exclusion Criteria1
- None
Interested in this trial?
Get notified about updates and connect with the research team.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT02806388
Related Trials
A Study to Evaluate Safety, Pharmacokinetics, and Activity of GDC-7035 as a Single Agent and in Combination in Patients With Advanced Solid Tumors
NCT0661958738 locations
NCI Childhood Cancer Data Initiative (CCDI) Led Pediatric, Adolescent, and Young Adult Rare Cancer Registry for Very Rare Solid Tumors
NCT074893781 location
Indocyanine Green (ICG) Guided Sentinel Lymph Node Mapping for Pediatric Visceral Solid Tumors
NCT056455233 locations
A Study to Assess IPN01194 When Administered Alone in Adults With Advanced Solid Tumours
NCT0630524712 locations
Safety and Tolerability of LDRT Plus Concurrent Partial SBRT and Tislelizumab in Patients With Bulky Tumors
NCT063498371 location